Skip to content

Privia Health

US · PRVA #2604 by market cap Listed 2021
25.05 +0.36 +1.46%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

After-hours 25.05 0.00%
28.1019.1025.052026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on PRVA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +14.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 3.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 96.3x Better than 4%
Forward P/E 50.2x Better than 7%
Price / Sales 1.3x Better than 71%
P/E vs own 5-yr range 43rd pctl Better than 65%
Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 16.1% Better than 77%
Net income CAGR (3Y) -9.6% Better than 27%
Free cash flow CAGR (3Y) 51.3% Better than 84%
Profitability C-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 9.9% Better than 6%
Operating margin 1.6% Better than 25%
Net margin 1.1% Better than 29%
Return on equity 3.3% Better than 33%
Return on invested capital 3.3% Better than 38%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 18.6% Better than 96%
6-month return 9.9% Better than 72%
12-month return (ex latest month) -5.6% Better than 27%
Distance below 52-week high 13.1% Better than 76%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 44%
Debt to assets 0.7% Better than 95%
Interest coverage -203.2x Better than 4%
Free cash flow / net income 713.0% Better than 95%
Analyst View B-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 83.3% Better than 63%
Upside to average target 21.8% Better than 36%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +2.04%
1M +9.25%
3M +18.16%
6M +8.07%
YTD +5.65%
1Y +11.09%
3Y +9.44%
5Y -13.17%

Key statistics

Price & volume

Prev close
24.69
Open
24.59
Day range
24.52 - 25.40
Avg price
25.11
Volume
1.93M
Turnover
48.45M
Amplitude
3.56%
52-week range
18.92 - 28.82

Valuation

P/E
139.17
P/E (TTM)
96.35
P/B
3.92
EPS
0.18
Net profit
23.00M
Net assets
815.67M

Share structure

Market cap
3.20B
Float cap
2.72B
Shares out
127.77M
Float shares
108.65M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2021-04-29
52-week range 62% of range
18.92 28.82

13.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-5.31M net over the window

Short interest

Shares short
3.90M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Privia Health (PRVA)?

Privia Health last traded at 25.05. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Privia Health's market cap?

About 3.20B.

What is the P/E ratio of Privia Health?

The trailing twelve-month P/E is 96.35, above its own 5-year average of 80.22 — in the middle of its historical range (43.46% percentile). See the Valuation tab for the full history.

Does Privia Health pay a dividend?

Privia Health does not currently pay a regular dividend.

Is Privia Health a buy according to analysts?

The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 30.50, which implies 21.8% upside from the current price. This is not investment advice.

What is Privia Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Privia Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Privia Health discussion 0 comments

Add a comment